CV Sciences, Inc. (CVSI) Financial Statements (2024 and earlier)

Company Profile

Business Address 9530 PADGETT STREET
SAN DIEGO, CA 92126
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,6907146111,1391,1142,439
Cash and cash equivalents1,6907146111,1391,1142,439
Receivables611657766695951930
Inventory, net of allowances, customer advances and progress billings5,8366,5266,5637,2267,3578,237
Inventory5,8366,5266,5637,2267,3578,237
Prepaid expense   3,190   
Other undisclosed current assets4112,103 3,1433,2173,448
Total current assets:8,54810,00011,13012,20312,63915,054
Noncurrent Assets
Operating lease, right-of-use asset222249275301326 
Property, plant and equipment4575165756356981,101
Intangible assets, net (including goodwill)2512512511,4851,4851,485
Intangible assets, net (excluding goodwill)2512512511,4851,4851,485
Other noncurrent assets401452505557610626
Total noncurrent assets:1,3311,4681,6062,9783,1193,212
TOTAL ASSETS:9,87911,46812,73615,18115,75818,266
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,6985,68211,97420,43320,85412,981
Employee-related liabilities8,4678,450
Accounts payable2,1612,4412,2842,2462,4732,705
Accrued liabilities3,5373,2419,6909,7209,93110,276
Debt     9521,036
Other undisclosed current liabilities1515711,340(6,898)(8,250)178
Total current liabilities:5,8496,25313,31413,53513,55614,195
Noncurrent Liabilities
Long-term debt and lease obligation:    219249 
Liabilities, other than long-term debt136168199626262
Deferred income tax liabilities111111626262
Operating lease, liability125157188219249 
Total noncurrent liabilities:13616819928131162
Total liabilities:5,9856,42113,51313,81613,86714,257
Equity
Equity, attributable to parent3,8945,047(777)1,3651,8914,009
Preferred stock      280
Common stock151515151412
Additional paid in capital87,15087,01586,89786,72686,22285,409
Accumulated deficit(83,271)(81,983)(87,689)(85,376)(84,345)(81,692)
Total equity:3,8945,047(777)1,3651,8914,009
TOTAL LIABILITIES AND EQUITY:9,87911,46812,73615,18115,75818,266

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues3,9664,1483,8693,7514,1384,447
Cost of revenue(2,248)(2,366)(2,307)(2,189)(2,868)(3,291)
Gross profit:1,7181,7821,5621,5621,2701,156
Operating expenses(2,794)(2,191)(3,687)(2,454)(3,585)(2,671)
Other undisclosed operating income  6,171    
Operating income (loss):(1,076)5,762(2,125)(892)(2,315)(1,515)
Nonoperating expense
(Other Nonoperating expense)
(209)     
Interest and debt expense    127  
Income (loss) from continuing operations before equity method investments, income taxes:(1,285)5,762(2,125)(765)(2,315)(1,515)
Other undisclosed loss from continuing operations before income taxes   (237)(266)(336) 
Income (loss) from continuing operations before income taxes:(1,285)5,762(2,362)(1,031)(2,651)(1,515)
Income tax expense (benefit) (3) 49 (2) 
Income (loss) from continuing operations:(1,288)5,762(2,313)(1,031)(2,653)(1,515)
Loss before gain (loss) on sale of properties:(1,031)(2,653)(1,515)
Net income (loss):(1,288)5,762(2,313)(1,031)(2,653)(1,515)
Other undisclosed net loss attributable to parent  (56)   (702)
Net income (loss) attributable to parent:(1,288)5,706(2,313)(1,031)(2,653)(2,217)
Other undisclosed net loss available to common stockholders, basic     (920) 
Net income (loss) available to common stockholders, diluted:(1,288)5,706(2,313)(1,031)(3,573)(2,217)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(1,288)5,762(2,313)(1,031)(2,653)(1,515)
Comprehensive income (loss), net of tax, attributable to parent:(1,288)5,762(2,313)(1,031)(2,653)(1,515)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: